Chronic atrophic gastritis(CAG), as a subtype of chronic gastritis, refers to the loss of gastric gland function in the inflammatory background caused by Helicobacter pylori (H.pylori) infection or autoimmune factors, with or without intestinal metaplasia(IM) , and is a precancerous disease. The main clinical manifestations of CAG are upper abdominal distension, early satiety, belching, decreased appetite, and irregular dull pain in the upper abdomen. As a clinically common and refractory disease, CAG can go on a long time. Traditional Chinese and western medicine in CAG are cut both ways, and this article provides a detailed description of the research progress on CAG to and provide some reference for clinic.

Lingyan Chen, Mengmeng Ye, Chunyan Liu, Chengyan Ma, Tao Yu. Progress in Clinical Research on Atrophic Gastritis in Traditional Chinese and Western Medicine. Academic Journal of Medicine & Health Sciences (2024), Vol. 5, Issue 1: 76-81. https://doi.org/10.25236/AJMHS.2024.050112.

[1] Shah Shailja C, Piazuelo M Blanca, Kuipers Ernst J, et al. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review [J]. Gastroenterology, 2021, 161(4):1325-1332.e7. 

[2] Correa P. A human model of gastric carcinogenesis [J]. Cancer research, 1988, 48(13):3554-3560.

[3] Vannella Lucy, Lahner Edith, Annibale Bruno, et al. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal [J]. World journal of gastroenterology, 2012, 18 (12):1279-1285.

[4] Wang Yajie, Guo Song, Yang Yang, et al. Epidemiological and risk factor analysis of chronic atrophic gastritis [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2019, 27(11):874-878.

[5] Du Yiqi, Bai Yu, Xie Pei, et al. Chronic gastritis in China: a national multi-center survey [J]. BMC gastroenterology, 2014, 14(1):21.

[6] Wang Nuanfeng, Chu Haikun, Huang Shumin, et al. Clinical characteristics of chronic atrophic gastritis patients in Heilongjiang province [J]. Chinese Journal of Public Health, 2017, 33(7):1109-1111.

[7] Sipponen Pentti, Maaroos Heidi-Ingrid. Chronic gastritis [J]. Scandinavian journal of gastroenterology, 2015, 50(6):657-667.

[8] Leja Mārcis, Grinberga-Derica Ieva, Bilgilier Ceren, et al. Review: Epidemiology of Helicobacter pylori infection [J]. Helicobacter, 2019, 241(1):e12635.

[9] Burucoa Christophe, Axon Anthony. Epidemiology of Helicobacter pylori infection [J]. Helicobacter, 2017, 221. 

[10] Camilo Vania, Sugiyama Toshiro, Touati Eliette, et al. Pathogenesis of Helicobacter pylori infection. [J]. Helicobacter, 2017, 221.

[11] Waskito Langgeng Agung, Salama Nina R, Yamaoka Yoshio, et al. Pathogenesis of Helicobacter pylori infection [J]. Helicobacter, 2018, 231:e12516.

[12] Shamshul Ansari, Yoshio Yamaoka. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity [J]. Toxins, 2019, 11(11):677-677.

[13] Skander Hathroubi, Stephanie L. Servetas, Ian Windham, et al. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis [J]. Microbiol. Mol. Biol. Rev., 2018, 82(2):e00001-e00018.

[14] Annibale Bruno, Esposito Gianluca, Lahner Edith, et al. A current clinical overview of atrophic gastritis [J]. Expert review of gastroenterology & hepatology, 2020, 14(2):93-102.

[15] Cheng Shuping, Zhang Qingyu, Li Ming, et al. Progress in diagnosis and treatment of chronic autoimmune atrophic gastritis [J]. Chinese Journal of Gastroenterology and Hepatology, 2021, 30(8): 940-945.

[16] Fu Yangxi, Han Xu, Liang Shuo, et al. Advances in the pathogenesis of chronic atrophic gastritis [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2023, 31(6):479-484.

[17] Yang Hong, Hou Jiayu. Experimental Study on Chronic Atrophic Gastritis Induced by Bile Reflux [J]. Journal of Beijing University of Traditional Chinese Medicine, 2001, 24(5):26-29.

[18] Matsuhisa Takeshi, Arakawa Tetsuo, Watanabe Tetsuo, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. [J]. Digestive endoscopy: official journal of the Japan Gastroenterological Endoscopy Society, 2013, 25(5):519-525.

[19] Su Baowei, Lin Qiang, Wang Jingjie. Relationship between bile reflux gastritis and intestinal metaplasia and related molecular mechanism [J]. Journal of Shanxi Medical University, 2021, 52(3): 344-349.

[20] Dong Tianyi, Lan Xiang, Fan Bingbing, et al. Gastric bacteria as potential biomarkers for the diagnosis of atrophic gastritis [J]. Molecular biology reports, 2022, 50(1):655-664.

[21] Sung Joseph J Y, Coker Olabisi Oluwabukola, Chu Eagle, et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication [J]. Gut, 2020, 69(9):1572-1580.

[22] Li Junxiang, Chen Jing, Lv Bin, et al. Consensus on the Diagnosis and Treatment of Chronic Atrophic Gastritis with Integrated Traditional Chinese and Western Medicine (2017) [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2018, 26(2):121-131.

[23] Redéen S, Petersson F, Jönsson K-A, et al. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample [J]. Endoscopy, 2003, 35(11):946-950.

[24] Zagari R M, Rabitti S, Greenwood D C, et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis [J]. Alimentary pharmacology & therapeutics, 2017, 46(7):657-667.

[25] Zhang Xuezhi, Wei Wei, Lan Yu. Chinese Medicine and Western Medicine Collaborative Expert Consensus on Diagnosis and Treatment of Helicobacter Pylori Caused Gastritis in Adults(2020,Beijing) [J]. Journal of Traditional Chinese Medicine, 2020, 61(22):2016-2024.

[26] Liu Wenzhong, Xie Yong, Lu Hong, et al. Fifth National Consensus Report on the Management of Helicobacter pylori Infection [J]. Chinese Journal of Gastroenterology, 2017, 22(6):346-360.

[27] Zhang Xin, Hu Dongqing, Zhou Xiaofeng, et al. Progress in diagnosis and treatment of chronic atrophic gastritis with depression and anxiety [J]. Shanxi Journal of Traditional Chinese Medicine, 2017, 33(12):55-57.

[28] Ge Wensong, Liu Jiemin, An Zhenxiang, et al. Exploration of Traditional Chinese Medicine in Reversing the Pathological Changes of Chronic Atrophic Gastritis [J]. Sichuan Journal of Traditional Chinese Medicine, 2004, 22(1):19-20.

[29] Yang Liangjun, Cai Tiantian, Li Jiali, et al. Systems Pharmacology Uncovers Multiple Mechanisms of Sijunzi Decoction for Treatment of Chronic Atrophic Gastritis [J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 46(9):1803-1806+2013.

[30] Xu Aili, Tang Bin, Wang Yuan, et al. Mechanism ofBanxia Xiexin Decoction in treating chronic atrophic gastritis by integrated pharmacology [J]. Beijing Journal of Traditional Chinese Medicine, 2019, 0(5):407-412.

[31] Zhou Wuai, Zhang Huan, Wang Xin, et al. Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis [J]. Phytomedicine, 2022, 95:153837-153837. 

[32] Ji Xu, Liu Lu, Du Xin, et al. Therapeutic Effect of Fast Needling of Fire Acupuncture Combined with Needle-Warming Moxibustion on CAG with Cold-Deficiency of Spleen and Stomach and Its Influence to Serum Levels of G17,PGI and PGR [J]. Journal of Clinical Acupuncture and Moxibustion, 2022, 38(4):32-36.